Katkó Mónika

1.

Galgóczi, E., Katkó, M., Borbély, S., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Agarose Gel Electrophoresis Reveals the Molecular Weight Distribution of Hyaluronan Produced by Orbital Fibroblasts.
Gels. 11 (6), 1-15, (article identifier: 406), 2025.

doi DEA WoS Scopus

Journal metrics:

Q2 Bioengineering (2024)

Q2 Biomaterials (2024)

Q1 Organic Chemistry (2024)

Q1 Polymers and Plastics (2024)

2.

Csiha, S., Hernyák, M., Molnár, Á., Lőrincz, H., Katkó, M., Paragh, G., Bodor, M., Harangi, M., Sztanek, F., Berta, E.: Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy.
Biomedicines. 13 (2), 1-16, (article identifier: 438), 2025.

doi DEA WoS Scopus

Journal metrics:

Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous) (2024)

Q1 Medicine (miscellaneous) (2024)

3.

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Stimulation of Piezo1 Mechanosensitive Channels Inhibits Adipogenesis in Thyroid Eye Disease.
J. Clin. Endocrinol. Metab. [Epub ahead of print], 2025.

doi DEA WoS

Journal metrics:

D1 Biochemistry (2024)

D1 Biochemistry (medical) (2024)

D1 Clinical Biochemistry (2024)

D1 Endocrinology (2024)

D1 Endocrinology, Diabetes and Metabolism (2024)

D1 Medicine (miscellaneous) (2024)

4.

Papp, F. R., Csiki, R., Katkó, M., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of hyaluronan metabolism during myofibroblast differentiation in orbital fibroblasts.
EJEA. 101, 20, 2024.

doi DEA

5.

Papp, F. R., Katkó, M., Csiki, R., Galgóczi, E., Molnár, Z., Erdei, A., Bodor, M., Steiber, Z., Ujhelyi, B., Nagy, E. V.: Characteristics of Hyaluronan Metabolism During Myofibroblast Differentiation in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 65 (13), 1-12, (article identifier: 13), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Cellular and Molecular Neuroscience

Q1 Ophthalmology

Q1 Sensory Systems

6.

Galgóczi, E., Molnár, Z., Katkó, M., Ujhelyi, B., Steiber, Z., Nagy, E. V.: Cyclosporin A inhibits PDGF-BB induced hyaluronan synthesis in orbital fibroblasts.
Chem.-Biol. Interact. 396, 1-7, (article identifier: 111045), 2024.

doi DEA WoS Scopus

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Toxicology

7.

Káplár, M., Esze, R., Rajnai, L., Képes, Z., Balkay, L., Somodi, S., Paragh, G., Katkó, M., Emri, M., Garai, I., Fülöp, P.: Impact of liver fat content on serum levels of plasminogen activator inhibitor-1, fibroblast growth factor 21 and cerebral microcirculation in type 2 diabetes and obesity.

DEA

8.

Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (article identifier: 565), 2024.

doi DEA WoS Scopus

Journal metrics:

Q2 Biochemistry

Q2 Endocrinology, Diabetes and Metabolism

Q2 Molecular Biology

9.

Galgóczi, E., Orsós, I., Molnár, Z., Ujhelyi, B., Steiber, Z., Szabó, L., Dienes, B., Csernoch, L., Nagy, E. V., Katkó, M.: Modelling of mechanical stimuli through piezo1 receptor activation and its effect on adipogenic differentiation of orbital fibroblasts.
EJEA. 101, 37, (article identifier: 0101), 2024.

doi DEA

10.

Sinkó, R., Katkó, M., Tóth, G., Kovács, G. L., Dohán, O., Fülöp, T., Costa, P., Dorogházi, B., Kővári, D., Nagy, E. V., Fekete, C., Gereben, B.: Novel biomarkers reveal mismatch between tissue and serum thyroid hormone status in amiodarone-induced hyperthyroidism.
J. Clin. Endocrinol. Metab. 110 (2), 374-386, 2024.

doi DEA

Journal metrics:

D1 Biochemistry

D1 Biochemistry (medical)

D1 Clinical Biochemistry

D1 Endocrinology

D1 Endocrinology, Diabetes and Metabolism

D1 Medicine (miscellaneous)

11.

Csiki, R., Papp, F. R., Galgóczi, E., Steiber, Z., Ujhelyi, B., Nagy, E. V., Katkó, M.: Production of chemerin by orbital fibroblasts during myofibroblast and adipocyte differentiation.
EJEA. 101, 38, 2024.

doi DEA

12.

Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14, 1-9, (article identifier: 1187725), 2023.

doi DEA WoS Scopus

Journal metrics:

Q1 Endocrinology, Diabetes and Metabolism

13.

Kerekes, G., Czókolyová, M., Hamar, A. B., Karancsiné Pusztai, A., Tajti, G., Katkó, M., Végh, E., Pethő, Z., Bodnár, N., Horváth, Á., Soós, B., Szamosi, S., Hascsi, Z., Harangi, M., Hódosi, K., Panyi, G., Seres, T., Szűcs, G., Szekanecz, Z.: Effects of 1-year tofacitinib therapy on angiogenic biomarkers in rheumatoid arthritis.
RHEUMATOLOGY. 62 (SI3), SI304-SI312, 2023.

doi DEA WoS Scopus

Journal metrics:

D1 Pharmacology (medical)

D1 Rheumatology

14.

Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H. P., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E. V.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.

DEA WoS Scopus

Journal metrics:

Q4 Endocrine and Autonomic Systems

Q4 Endocrinology

Q4 Endocrinology, Diabetes and Metabolism

Q4 Medicine (miscellaneous)

Q4 Neurology

Q4 Neurology (clinical)

Q4 Psychiatry and Mental Health

15.

Csiha, S., Halmi, S., Hutkai, D., Molnár, I., Katkó, M., Lőrincz, H., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M., Berta, E.: Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81, EP400, 2022.

doi DEA

16.

Lengyel, I., Halmi, S., Lőrincz, H., Csiha, S., Katkó, M., Harangi, M., Nagy, E. V., Paragh, G., Bodor, M., Berta, E.: Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355, e247-e248, 2022.

doi DEA

17.

Aranyosi, J. K., Galgóczi, E., Erdei, A., Katkó, M., Fodor, M., Ujhelyi, Z., Bácskay, I., Nagy, E. V., Ujhelyi, B.: Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.
Molecules. 27 (9), 1-14, 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

18.

Galgóczi, E., Katkó, M., Papp, F. R., Csiki, R., Csiha, S., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: Glucocorticoids Directly Affect Hyaluronan Production of Orbital Fibroblasts: a Potential Pleiotropic Effect in Graves' Orbitopathy.
Molecules. 28 (1), 1-12, (article identifier: 15), 2022.

doi DEA WoS Scopus

Journal metrics:

Q2 Analytical Chemistry

Q2 Chemistry (miscellaneous)

Q2 Drug Discovery

Q2 Medicine (miscellaneous)

Q3 Molecular Medicine

Q2 Organic Chemistry

Q1 Pharmaceutical Science

Q2 Physical and Theoretical Chemistry

19.

Taybani, Z., Bótyik, B., Gyimesi, A., Katkó, M., Várkonyi, T.: One-year safety and efficacy results of insulin treatment simplification with in type 2 diabetes.
Endocrino Diabet & Metabol. 6 (1), 1-7, (article identifier: 390), 2022.

doi DEA Scopus

20.

Lőrincz, H., Galgóczi, E., Katkó, M., Ratku, B., Ötvös, T., Harangi, M., Paragh, G., Szabó, Z., Somodi, S.: Plasminogen activator inhibitor-1 level associated with the components of metabolic syndrome in a 4G/5G polymorphism dependent manner.
Atherosclerosis. 355, e248, 2022.

doi DEA

21.

Cogoi, B., Esze, R., Rajnai, L., Somodi, S., Shemirani, A. H., Bereczky, Z., Paragh, G., Katkó, M., Káplár, M.: Protective effect of factor XIII Intron-K G allele on subclinical atherosclerosis.

DEA

22.

Galgóczi, E., Katkó, M., Erdei, A., Bodor, M., Ujhelyi, B., Steiber, Z., Győry, F., Nagy, E. V.: The effect of glucocorticoids on hyaluronan production of orbital fibroblasts.
Endocrine Abst. 84, PS2-07-64, 2022.

doi DEA

23.

Katkó, M., Gazdag, A., Harangi, M., Szentpéteri, A., Galgóczi, E., Erdei, A., Berta, E., Bodor, M., Bhattoa, H. P., Nagy, E. V.: The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355, e163, 2022.

doi DEA

24.

Sztanek, F., Demeter, Z., Katkó, M., Molnár, Á., Jakab, A. Á., Harangi, M.: A diabeteses autonóm neuropathia vizsgálata a Debreceni Egyetem Diabeteses Neuropathia Centrum betegeinek körében kérdőíves módszer segítségével.
Diabetol. Hung. 29 (1), 39-46, 2021.

doi DEA

25.

Sámson, L., Hircsu, I., Katkó, M., Bodor, M., Gazdag, A., Gazsó, A., Kovács, B., Posta, J., Balogh, E., Mocsáry, P., Bhattoa, H. P., Nagy, E. V.: Lower educational status interferes with maternal iodine intake during both pregnancy and lactation.
Endocr. Connect. 10 (7), 742-749, 2021.

doi DEA WoS Scopus

Journal metrics:

Q2 Endocrinology

Q2 Endocrinology, Diabetes and Metabolism

Q2 Internal Medicine

Katkó Mónika

Publication list